Molecular evidence of genome editing in a mouse model of immunodeficiency
Genome editing is the introduction of directed modifications in the genome, a process boosted to therapeutic levels by designer nucleases. Building on the experience of ex vivo gene therapy for severe combined immunodeficiencies, it is likely that genome editing of haematopoietic stem/progenitor cel...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
29 May 2018
|
| In: |
Scientific reports
Year: 2018, Jahrgang: 8 |
| ISSN: | 2045-2322 |
| DOI: | 10.1038/s41598-018-26439-9 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1038/s41598-018-26439-9 Verlag, Volltext: https://www.nature.com/articles/s41598-018-26439-9 
|
| Verfasserangaben: | H.H. Abdul-Razak, C.J. Rocca, S.J. Howe, M.E. Alonso-Ferrero, J. Wang, R. Gabriel, C.C. Bartholomae, C.H.V. Gan, M.I. Garín, A. Roberts, M.P. Blundell, V. Prakash, F.J. Molina-Estevez, J. Pantoglou, G. Guenechea, M.C. Holmes, P.D. Gregory, C. Kinnon, C. von Kalle, M. Schmidt, J.A. Bueren, A.J. Thrasher & R.J. Yáñez-Muñoz |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1662708122 | ||
| 003 | DE-627 | ||
| 005 | 20230426154234.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190402s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41598-018-26439-9 |2 doi | |
| 035 | |a (DE-627)1662708122 | ||
| 035 | |a (DE-599)KXP1662708122 | ||
| 035 | |a (OCoLC)1341205851 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Abdul-Razak, Hayder |e VerfasserIn |0 (DE-588)1182702937 |0 (DE-627)1662865252 |4 aut | |
| 245 | 1 | 0 | |a Molecular evidence of genome editing in a mouse model of immunodeficiency |c H.H. Abdul-Razak, C.J. Rocca, S.J. Howe, M.E. Alonso-Ferrero, J. Wang, R. Gabriel, C.C. Bartholomae, C.H.V. Gan, M.I. Garín, A. Roberts, M.P. Blundell, V. Prakash, F.J. Molina-Estevez, J. Pantoglou, G. Guenechea, M.C. Holmes, P.D. Gregory, C. Kinnon, C. von Kalle, M. Schmidt, J.A. Bueren, A.J. Thrasher & R.J. Yáñez-Muñoz |
| 264 | 1 | |c 29 May 2018 | |
| 300 | |a 13 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 02.04.2019 | ||
| 520 | |a Genome editing is the introduction of directed modifications in the genome, a process boosted to therapeutic levels by designer nucleases. Building on the experience of ex vivo gene therapy for severe combined immunodeficiencies, it is likely that genome editing of haematopoietic stem/progenitor cells (HSPC) for correction of inherited blood diseases will be an early clinical application. We show molecular evidence of gene correction in a mouse model of primary immunodeficiency. In vitro experiments in DNA-dependent protein kinase catalytic subunit severe combined immunodeficiency (Prkdc scid) fibroblasts using designed zinc finger nucleases (ZFN) and a repair template demonstrated molecular and functional correction of the defect. Following transplantation of ex vivo gene-edited Prkdc scid HSPC, some of the recipient animals carried the expected genomic signature of ZFN-driven gene correction. In some primary and secondary transplant recipients we detected double-positive CD4/CD8 T-cells in thymus and single-positive T-cells in blood, but no other evidence of immune reconstitution. However, the leakiness of this model is a confounding factor for the interpretation of the possible T-cell reconstitution. Our results provide support for the feasibility of rescuing inherited blood disease by ex vivo genome editing followed by transplantation, and highlight some of the challenges. | ||
| 700 | 1 | |a Gabriel, Richard |e VerfasserIn |0 (DE-588)1017959846 |0 (DE-627)690473427 |0 (DE-576)354092332 |4 aut | |
| 700 | 1 | |a Bartholomä, Cynthia C. |e VerfasserIn |0 (DE-588)1036481042 |0 (DE-627)751079243 |0 (DE-576)384489524 |4 aut | |
| 700 | 1 | |a Kalle, Christof von |d 1962- |e VerfasserIn |0 (DE-588)1036481115 |0 (DE-627)75107926X |0 (DE-576)168957396 |4 aut | |
| 700 | 1 | |a Schmidt, Michael |d 1984- |e VerfasserIn |0 (DE-588)106280225X |0 (DE-627)806958960 |0 (DE-576)420222715 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Scientific reports |d [London] : Springer Nature, 2011 |g 8(2018) Artikel-Nummer 8214, 13 Seiten |h Online-Ressource |w (DE-627)663366712 |w (DE-600)2615211-3 |w (DE-576)346641179 |x 2045-2322 |7 nnas |a Molecular evidence of genome editing in a mouse model of immunodeficiency |
| 773 | 1 | 8 | |g volume:8 |g year:2018 |g extent:13 |a Molecular evidence of genome editing in a mouse model of immunodeficiency |
| 856 | 4 | 0 | |u https://doi.org/10.1038/s41598-018-26439-9 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/s41598-018-26439-9 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190402 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 106280225X |a Schmidt, Michael |m 106280225X:Schmidt, Michael |d 910000 |e 910000PS106280225X |k 0/910000/ |p 20 | ||
| 998 | |g 1036481115 |a Kalle, Christof von |m 1036481115:Kalle, Christof von |d 910000 |e 910000PK1036481115 |k 0/910000/ |p 19 | ||
| 998 | |g 1036481042 |a Bartholomä, Cynthia C. |m 1036481042:Bartholomä, Cynthia C. |d 140000 |e 140000PB1036481042 |k 0/140000/ |p 7 | ||
| 998 | |g 1017959846 |a Gabriel, Richard |m 1017959846:Gabriel, Richard |d 140000 |e 140000PG1017959846 |k 0/140000/ |p 6 | ||
| 999 | |a KXP-PPN1662708122 |e 3417717833 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"doi":["10.1038/s41598-018-26439-9"],"eki":["1662708122"]},"origin":[{"dateIssuedDisp":"29 May 2018","dateIssuedKey":"2018"}],"name":{"displayForm":["H.H. Abdul-Razak, C.J. Rocca, S.J. Howe, M.E. Alonso-Ferrero, J. Wang, R. Gabriel, C.C. Bartholomae, C.H.V. Gan, M.I. Garín, A. Roberts, M.P. Blundell, V. Prakash, F.J. Molina-Estevez, J. Pantoglou, G. Guenechea, M.C. Holmes, P.D. Gregory, C. Kinnon, C. von Kalle, M. Schmidt, J.A. Bueren, A.J. Thrasher & R.J. Yáñez-Muñoz"]},"recId":"1662708122","person":[{"display":"Abdul-Razak, Hayder","role":"aut","given":"Hayder","family":"Abdul-Razak"},{"display":"Gabriel, Richard","given":"Richard","role":"aut","family":"Gabriel"},{"role":"aut","given":"Cynthia C.","family":"Bartholomä","display":"Bartholomä, Cynthia C."},{"given":"Christof von","role":"aut","family":"Kalle","display":"Kalle, Christof von"},{"display":"Schmidt, Michael","family":"Schmidt","given":"Michael","role":"aut"}],"title":[{"title_sort":"Molecular evidence of genome editing in a mouse model of immunodeficiency","title":"Molecular evidence of genome editing in a mouse model of immunodeficiency"}],"language":["eng"],"physDesc":[{"extent":"13 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"title":[{"title":"Scientific reports","title_sort":"Scientific reports"}],"note":["Gesehen am 12.07.24"],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1, article number 1 (2011)-"],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"origin":[{"publisher":"Springer Nature ; Nature Publishing Group","dateIssuedKey":"2011","dateIssuedDisp":"2011-","publisherPlace":"[London] ; London"}],"id":{"issn":["2045-2322"],"zdb":["2615211-3"],"eki":["663366712"]},"part":{"extent":"13","text":"8(2018) Artikel-Nummer 8214, 13 Seiten","volume":"8","year":"2018"},"recId":"663366712","disp":"Molecular evidence of genome editing in a mouse model of immunodeficiencyScientific reports"}],"note":["Gesehen am 02.04.2019"]} | ||
| SRT | |a ABDULRAZAKMOLECULARE2920 | ||